DNA demethylation of vascular endothelial growth factor-C is associated with gene expression and its possible involvement of lymphangiogenesis in gastric cancer
✍ Scribed by Shunji Matsumura; Naohide Oue; Yoshitsugu Mitani; Yasuhiko Kitadai; Wataru Yasui
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- French
- Weight
- 623 KB
- Volume
- 120
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Previous studies have indicated that lymphangiogenesis in solid tumors is associated with lymphatic metastasis. Overexpression of Vascular endothelial growth factor (VEGF)‐C plays a major role in lymphangiogenesis in cancers. In the present study, DNA methylation and expression of the VEGF‐C gene was investigated in gastric cancer (GC). Four GC cell lines (MKN‐45, MKN‐74, HSC‐39 and HSC‐43) showed no expression of VEGF‐C, and the VEGF‐C gene was found to be methylated in these cells. In contrast, 7 GC cell lines (MKN‐1, MKN‐7, MKN‐28, TMK‐1, KATO‐III, SH101‐P4 and HSC‐44PE) expressed VEGF‐C, and the VEGF‐C gene was found to be unmethylated in these cell lines. In addition, expression of VEGF‐C mRNA was retrieved by treatment with a demethylating agent, Aza‐2′‐deoxycytidine. In GC tissue samples, bisulfite DNA sequencing analysis revealed that VEGF‐C was not methylated in 9 (29.0%) of 31 GC samples, whereas demethylation was not observed in corresponding non‐neoplastic mucosa samples. Overexpression of VEGF‐C mRNA was observed in 16 (51.6%) of 31 GC samples by quantitative reverse transcription‐polymerase chain reaction. Of the 9 GC cases with VEGF‐C demethylation, 8 (88.9%) overexpressed VEGF‐C. In contrast, of the 22 GC cases without VEGF‐C demethylation, 8 (36.4%) overexpressed VEGF‐C (p = 0.0155). Furthermore, lymphatic vessel density determined by immunostaining of podoplanin in GC tissues was associated with overexpression of VEGF‐C (p < 0.0001). These results suggest that demethylation and activation of the VEGF‐C gene is likely involved in lymphangiogenesis in GC. © 2007 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract A common 936 C/T polymorphism in the gene for the vascular endothelial growth factor (VEGF) has been associated with VEGF plasma levels. In our case‐control study, we investigated the role of this polymorphism for breast cancer risk. VEGF genotype was determined in 500 women with breast
The immunolocalization and gene expression of vascular endothelial growth factor (VEGF) and its cognate tyrosine kinase receptors, Flt-1 and KDR, has been studied in ocular melanomas and retinoblastomas using in situ hybridization and immunohistochemistry. Tumour-related alterations in VEGF/VEGF-rec